Prostaglandin E2 Resistance of Nasal Fibroblast in Aspirin Exacerbated Respiratory Disease Is Caused by Epigenetic Factor Defects in EP2 Receptor Expression

被引:0
|
作者
Cahill, Katherine N. [1 ,2 ]
Kidder, Molly [1 ]
Bhattacharyya, Neil [2 ,3 ]
Borish, Larry [4 ]
Steinke, John W. [4 ]
Boyce, Joshua A. [1 ,2 ]
Laidlaw, Tanya M. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Div Otolaryngol, Boston, MA 02115 USA
[4] Univ Virginia, Carter Ctr Immunol Res, Asthma & Allerg Dis Ctr, Charlottesville, VA USA
关键词
D O I
10.1016/j.jaci.2012.12.1549
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB328 / AB328
页数:1
相关论文
共 50 条
  • [1] Reduced EP2 Receptor Expression Accounts For Prostaglandin E2 Resistance In Nasal Polyp Fibroblasts From Patients With Aspirin Exacerbated Respiratory Disease; Possible Role For Histone Acetylation In Control Of EP2 Receptor Expression
    Cahill, Katherine N.
    Thibault, Derek
    Raby, Benjamin A.
    Baccarelli, Andrea
    Bhattacharyya, Neil
    Boyce, Joshua A.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB77 - AB77
  • [2] Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease
    Cahill, Katherine N.
    Raby, Benjamin A.
    Zhou, Xiaobo
    Guo, Feng
    Thibault, Derek
    Baccarelli, Andreas
    Byun, Hyang-Min
    Bhattacharyya, Neil
    Steinke, John W.
    Boyce, Joshua A.
    Laidlaw, Tanya M.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2016, 54 (01) : 34 - 40
  • [3] Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    Cutler, Anya J.
    Kidder, Molly S.
    Liu, Tao
    Cardet, Juan Carlos
    Chhay, Heng
    Feng, Chunli
    Boyce, Joshua A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (06) : 1692 - +
  • [4] Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist
    Choudhary, Shilpa
    Alander, Cynthia
    Zhan, Peili
    Gao, Qi
    Pilbeam, Carol
    Raisz, Lawrence
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2008, 86 (1-4) : 35 - 40
  • [5] Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype
    Nemoto, K
    Pilbeam, CC
    Bilak, SR
    Raisz, LG
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1997, 54 (04): : 713 - 725
  • [6] Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
    Matsubara, Shin
    Shiraishi, Akira
    Sakai, Tsubasa
    Okuda, Toshimi
    Satake, Honoo
    PLOS ONE, 2017, 12 (11):
  • [7] Prostaglandin E2 receptor EP2 mediates Snail expression in hepatocellular carcinoma cells
    Cheng, Shan-Yu
    Zhang, Hai
    Zhang, Min
    Xia, Shu-Kai
    Bai, Xiao-Ming
    Zhang, Li
    Ma, Juan
    Rong, Rong
    Wang, Yi-Pin
    Du, Ming-Zhan
    Wang, Jie
    Chen, Meng
    Shi, Feng
    Yang, Qin-Yi
    Leng, Jing
    ONCOLOGY REPORTS, 2014, 31 (05) : 2099 - 2106
  • [8] The Double Roles of the Prostaglandin E2 EP2 Receptor in Intracerebral Hemorrhage
    Luo, Xu
    Zhu, Qiquan
    Zhang, Jie
    Huang, Qin
    Xie, Zongyi
    Cheng, Yuan
    CURRENT DRUG TARGETS, 2017, 18 (12) : 1377 - 1385
  • [9] Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines
    Peng, Lin
    Ye, Yao
    Mullikin, Heather
    Lin, LiLi
    Kuhn, Christina
    Rahmeh, Martina
    Mahner, Sven
    Jeschke, Udo
    von Schonfeldt, Viktoria
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 142
  • [10] Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
    Sung, YM
    He, GB
    Fischer, SM
    CANCER RESEARCH, 2005, 65 (20) : 9304 - 9311